VIG dividend yield: 1.29%. MRK dividend yield: 3.25%. VIG tracks companies that have grown their dividends for 10+ consecutive years — the definition of dividend quality. With 315+ holdings and 0.06% expense ratio, it's a core holding for dividend growth investors. Lower current yield but superior long-term dividend growth versus high-yield alternatives. Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
VIG tracks companies that have grown their dividends for 10+ consecutive years — the definition of dividend quality. With 315+ holdings and 0.06% expense ratio, it's a core holding for dividend growth investors. Lower current yield but superior long-term dividend growth versus high-yield alternatives.
Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
VIG currently offers a 1.29% yield (2.40/share/year) while MRK offers 3.25% (3.08/share/year). MRK provides higher current income. However, VIG has grown its dividend faster (9.2% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in VIG vs MRK earn per year?
With $10,000 invested today: VIG pays approximately $129/year. MRK pays approximately $325/year. With DRIP reinvestment over 10 years, these grow to $346/year (VIG) and $950/year (MRK).
Does VIG or MRK pay monthly dividends?
VIG pays quarterly dividends. MRK pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this VIG vs MRK comparison by email
Save your analysis + get weekly dividend insights. Free forever.